You can buy or sell ALNA and other stocks, options, and ETFs commission-free!
Allena Pharmaceuticals, Inc. engages in the development, discovery and commercialization of oral enzyme therapeutics to treat patients with kidney disorders. Its product pipeline includes reloxaliase, an oral enzyme therapeutic for the treatment of enteric hyperoxaluria in adults and ALLN-346, which is used for patients with hyperuricemia and moderate to severe chronic kidney disease.
52 Week High
52 Week Low
-$0.23 per share
-$0.21 per share